A pharmaceutical composition in the form of a multiphase (especially a bilayered, optionally coated) tablet. The tablet has a narcotic analgesic phase containing a therapeutically effective quantity of a narcotic analgesic or an analgesically effective salt thereof (e.g. codeine phosphate) and a non-steroidal anti-inflammatory phase containing a therapeutically effective quantity of a non-steroidal anti-inflammatory carboxylic acid or an anti-inflammatory salt or ester thereof (e.g. ibuprofen). The narcotic analgesic phase is free from a non-steroidal anti-inflammatory carboxylic acid or salt or ester thereof, stearic acid and stearate salt, and the non-steroidal anti-inflammatory phase is free from a narcotic analgesic or salt thereof, stearic acid and a stearate salt. Further, both the narcotic analgesic phase and the non-steroidal anti-inflammatory phase contain a self-lubricating, compression aid, especially a self-lubricating, direct compression aid, such as microcrystalline cellulose.
一种多相制剂形式的药物组合物(尤其是双层,可选涂层的)片剂。该片剂具有含有镇痛
麻醉剂量或其镇痛有效盐(例如
磷酸可待因)的镇痛麻醉相和含有非甾体抗炎
羧酸或其抗炎盐或酯的治疗有效量的非甾体抗炎相(例如
布洛芬)的组合相。镇痛麻醉相不含非甾体抗炎
羧酸或其盐或酯,
硬脂酸和
硬脂酸盐,而非甾体抗炎相不含镇痛
麻醉剂或其盐,
硬脂酸和
硬脂酸盐。此外,镇痛麻醉相和非甾体抗炎相都含有自润滑的压缩辅助剂,尤其是自润滑的直接压缩辅助剂,如
微晶纤维素。